Published in J Immunol on December 01, 2006
Mechanism and regulation of class switch recombination. Annu Rev Immunol (2008) 5.98
Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol (2008) 5.37
The biology of intestinal immunoglobulin A responses. Immunity (2008) 3.18
The regulation of IgA class switching. Nat Rev Immunol (2008) 2.92
Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol (2010) 2.85
IgH chain class switch recombination: mechanism and regulation. J Immunol (2014) 2.27
Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood (2011) 2.15
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology (2008) 1.89
New concepts in the generation and functions of IgA. Nat Rev Immunol (2012) 1.81
Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol (2011) 1.40
The role of secretory antibodies in infection immunity. Nat Rev Microbiol (2010) 1.36
Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J Immunol (2008) 1.35
Innate control of B cell responses. Trends Immunol (2011) 1.21
Intestinal bacteria condition dendritic cells to promote IgA production. PLoS One (2008) 1.13
Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood (2008) 1.11
An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol (2008) 1.04
IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production. Mucosal Immunol (2015) 1.00
Innate signaling networks in mucosal IgA class switching. Adv Immunol (2010) 0.97
Intestinal IgA production and its role in host-microbe interaction. Immunol Rev (2014) 0.96
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J Immunol (2010) 0.95
Regulation of mucosal IgA responses: lessons from primary immunodeficiencies. Ann N Y Acad Sci (2011) 0.95
The role of Peyer's patches in synchronizing gut IgA responses. Front Immunol (2012) 0.92
Interleukin (IL)-21 promotes intestinal IgA response to microbiota. Mucosal Immunol (2015) 0.91
Isolated Lymphoid Follicles are Dynamic Reservoirs for the Induction of Intestinal IgA. Front Immunol (2012) 0.88
The intestinal B-cell response in celiac disease. Front Immunol (2012) 0.84
The human intestinal IgA response; burning questions. Front Immunol (2012) 0.84
The gastrointestinal frontier: IgA and viruses. Front Immunol (2013) 0.82
Translating transitions - how to decipher peripheral human B cell development. J Biomed Res (2015) 0.81
Regulation of frontline antibody responses by innate immune signals. Immunol Res (2012) 0.81
Localization of fatty acid binding protein of epidermal type common to dendritic cells and presumptive macrophages in Peyer's patches and epithelial M cells of mouse intestine. Histochem Cell Biol (2009) 0.77
Peyer's patches: organizing B-cell responses at the intestinal frontier. Immunol Rev (2016) 0.76
Tissue adaptation: Implications for gut immunity and tolerance. J Exp Med (2017) 0.75
The regulation of gut mucosal IgA B-cell responses: recent developments. Mucosal Immunol (2017) 0.75
Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins. Cell Rep (2017) 0.75
REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J Biol Chem (2006) 1.61
Pivotal advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation. J Leukoc Biol (2011) 1.45
T cell-independent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation. J Immunol (2010) 1.11
Induction of gut IgA production through T cell-dependent and T cell-independent pathways. Ann N Y Acad Sci (2012) 1.07
The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection. PLoS Pathog (2010) 1.05
Immortalized mouse cell lines that lack a functional Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment. DNA Repair (Amst) (2004) 1.03
Immunology of the human genital tract. Curr Opin Infect Dis (2003) 0.99
Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection. Infect Immun (2007) 0.97
The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues. J Immunol (2004) 0.97
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine (2002) 0.92
CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization. Eur J Immunol (2011) 0.92
A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development. J Immunol (2011) 0.92
The role of Peyer's patches in synchronizing gut IgA responses. Front Immunol (2012) 0.92
IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol (2005) 0.90
The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Infect Immun (2006) 0.89
Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine (2007) 0.87
Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant. J Immunol (2011) 0.86
A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus. Vaccine (2011) 0.84
CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization. J Gen Virol (2008) 0.84
ADP-ribosylation controls the outcome of tolerance or enhanced priming following mucosal immunization. J Immunol (2010) 0.81
The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells. J Immunol (2006) 0.81
Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PLoS One (2013) 0.79
Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas. Cancer Immunol Immunother (2013) 0.75
The 18th Germinal Centre Meeting. Scand J Immunol (2014) 0.75